Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-16-002728
Filing Date
2016-09-15
Accepted
2016-09-15 17:37:02
Documents
2
Period of Report
2016-09-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3019
2 POWER OF ATTORNEY morganlampoa.htm EX-24 6962
  Complete submission text file 0001123292-16-002728.txt   11408
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KALOBIOS PHARMACEUTICALS, INC. 1000 MARINA BOULEVARD, SUITE 250 BRISBANE CA 94005-1878
Business Address
Lam Morgan (Reporting) CIK: 0001684780 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35798 | Film No.: 161887866